Latest News of OCUP
Ocuphire and Opus Genetics merge to develop IRD gene therapy
By Yahoo! Finance |
3 weeks ago
Ocuphire Pharma acquires Opus Genetics to form Opus Genetics, focusing on gene therapy for inherited retinal diseases. The merger involves stock issuance and preferred shares conversion, aiming to acc...
Here's Why We're Not At All Concerned With Ocuphire Pharma's (NASDAQ:OCUP) Cash Burn Situation
By Yahoo! Finance |
3 months ago
Investors are attracted to unprofitable companies due to potential high returns. Ocuphire Pharma's cash burn analysis reveals a long cash runway despite falling revenue, indicating its ability to mana...